The pancreatic beta-cell recognition of insulin secretogogues. Influence of neuraminidase treatment on the release of insulin and the islet content of insulin, sialic acid, and cyclic adenosine 3':5'-monophosphate.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001894:Borohydrides; D003994:Bucladesine / Q000494:pharmacology; D002264:Carboxylic Acids / Q000494:pharmacology; D003016:Clostridium perfringens / Q000201:enzymology; D000242:Cyclic AMP / Q000378:metabolism*; D005215:Fasting; D005934:Glucagon / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007330:Insulin Antibodies; D000078790:Insulin Secretion; D007457:Iodine Radioisotopes; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D051379:Mice; D009438:Neuraminic Acids / Q000378:metabolism*; D009439:Neuraminidase / Q000502:physiology*; D011863:Radioimmunoassay; D013053:Spectrophotometry; D013552:Swine; D013806:Theophylline / Q000494:pharmacology
D000963:Antimetabolites; D001894:Borohydrides; D002264:Carboxylic Acids; D007328:Insulin; D007330:Insulin Antibodies; D007457:Iodine Radioisotopes; D009438:Neuraminic Acids; D003994:Bucladesine; D005934:Glucagon; D013806:Theophylline; D000242:Cyclic AMP; D009439:Neuraminidase